NRI from all over the world (including U.S.A. & Canada) can invest in this fund

INVEST VIA NRE/NRO

Nippon India Pharma Fund - Growth for NRI [516.98]

Min Investment

5,000

Fund Size

8,647.95 Cr

Expense Ratio

1.8%

Exit Load

1%

SBNRI is a certified Mutual Fund distributor registered with Association of Mutual Funds in India (AMFI) with Reg. No. 246671

516.98

-0.28%

NAV as on 06 Oct 24, 12:00 AM

very high risk

sector healthcare

equity

NAV as on 06 Oct 24, 12:00 AM

very high risk

sector healthcare

equity

48.92%p.a.

Last 1Y

17.84%p.a.

Last 3Y

30.06%p.a.

Last 5Y

21.50%p.a.

Since Inception

About Nippon India Pharma Fund - Growth for NRIs

NRIs can achieve long-term capital appreciation by investing in the Nippon India Pharma Fund - Growth scheme from Nippon Life India Asset Management Ltd. It is a Sector - Healthcare mutual fund scheme that predominantly invests in Sector - Healthcare stocks of companies. Launched on Jun 2004, Nippon India Pharma Fund - Growth is Sector - Healthcare fund of its category with 8,647.95 Cr fund under management as on Oct 2024. The expense ratio of this fund is less than that of most other Fund category Sector - Healthcare funds.

  • Nippon India Pharma Fund - Growth delivered 48.9% annual returns during the last year. It has delivered 21.5% average annual returns since the fund was launched.
  • Nippon India Pharma Fund - Growth scheme tends to consistently deliver higher returns than most schemes in the same category.
  • The scheme has predominantly invested in equity

Fund Objective

The primary investment objective of the scheme is to seek to generate consistent returns by investing in equity and equity related or fixed income securities of Pharma and other associated companies.

Top 10 Holdings

Sun Pharmaceuticals Industries Ltd

13.81%

Lupin Ltd

8.30%

Divi's Laboratories Ltd

7.96%

Cipla Ltd

5.93%

Dr Reddy's Laboratories Ltd

5.69%

Apollo Hospitals Enterprise Ltd

5.20%

Ajanta Pharma Ltd

3.60%

Vijaya Diagnostic Centre Ltd

3.19%

Gland Pharma Ltd

3.19%

Aurobindo Pharma Ltd

3.09%

Fund Managers

  1. Sailesh Raj Bhan (Apr 2005 - Present)
  2. Kinjal Desai (May 2018 - Present)

Key Information

View Scheme Document

Nippon India Pharma Fund - Growth SIP Calculator

If invested

5,000

per month

For a period of

Investment of 0 could have been

0(+0.0%)

0 (+0.0%)

This Fund

0 (+0.0%)

Fixed Deposit

NRI Mutual Fund Tax on Nippon India Pharma Fund - Growth

Just like for resident investors, capital gains from mutual fund investments are subject to income tax for NRI investors.

Fund TypeShort-term Capital Gains (STCG) TaxLong-term Capital Gains (LTCG) Tax
Equity mutual funds15%10% (above Rs. 1 lakh LTCG) without indexation*
Debt & other types of fundsAt tax slab rate20% with indexation benefits

How can NRIs invest in Nippon India Pharma Fund - Growth?

NRIs and OCIs can download the SBNRI app to invest in mutual funds from the country of their residence. Here are a few simple steps you need to take:

  • Complete your NRI KYC: Type in your personal details and attach supporting documents, like:
  • PAN Number
  • Overseas address proof: Any of – Water/electricity bill, postpaid mobile/internet bill, rent agreement, driving license, etc.
  • Passport – front and back
  • Passport size photograph
  • signature

If all details are correct, your KYC will be approved within 7 to 8 business days.

  • Onboarding: After KYC, you need to share the following details to complete onboarding process and start investing in Nippon India Pharma Fund - Growth
  • Onboarding: After KYC, you need to share the following details to complete onboarding process and start investing:
  • City and country of birth
  • NRE/NRO bank account statement/ canceled cheque for the latest 3 months
  • Nominee details

Frequently Asked Questions